501PPhase II study of nedaplatin plus amrubicin in patients with untreated, advanced or relapsed squamous cell lung cancer. (25th November 2018) - Suyama, T; Taniguchi, H; Ikeda, T; Yamaguchi, H; Kitazaki, T; Soda, H; Nakatomi, K; Kinosita, A; Fukuda, M; Mukae, H